In this episode, Michelle examines President Biden's decision to intensify AI chip export restrictions and the resulting implications for global AI innovation and supply chains. She explores how these restrictions are influencing China's AI advancements and their strategic responses. The episode also delves into AI's growing role in methane mitigation and recent breakthroughs in agriculture, highlighting the technology's potential to address environmental challenges. Additionally, the episode features a segment on the partnership between Novo Nordisk and Valo Health in AI-driven drug development as a sponsor. The episode concludes with reflections on these developments and their broader impact on the AI landscape.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related